Immunofluorescence staining was conducted to assess antioxidant capacity via SOD expression and to evaluate macrophage polarization using CD86 (M1 marker) and CD206 (M2 marker)
Obesity is associated with immunometabolic changes in adipose tissue that may drive treatment resistance in breast cancer: immune-metabolic reprogramming and novel therapeutic strategies
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
GshA (PRK02107, PRK13516, PRK13518, PRK13517, PRK13515), GshB (PRK12458, PRK05246), GshF (PRK02471), Gpo (PRK10606), GST (PRK11752, PRK10357, PRK10542), Ggt (PRK09615), CydC (PRK11160) and CydD (PRK11174)
This essential coenzyme is critical for maintaining optimal cellular performance and preventing age-related functional decline